298 related articles for article (PubMed ID: 23364471)
1. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
Yokota S; Hikasa Y; Mizushima H
Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
[TBL] [Abstract][Full Text] [Related]
2. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
[TBL] [Abstract][Full Text] [Related]
3. The effects of imidazoline agents on the aggregation of human platelets.
Pinthong D; Songsermsakul P; Rattanachamnong P; Kendall DA
J Pharm Pharmacol; 2004 Feb; 56(2):213-20. PubMed ID: 15005880
[TBL] [Abstract][Full Text] [Related]
4. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets.
Yokota S; Hikasa Y; Shimura I; Kusunose S
Am J Vet Res; 2013 Mar; 74(3):395-402. PubMed ID: 23438114
[TBL] [Abstract][Full Text] [Related]
5. Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets.
Matsukawa T; Hikasa Y
Am J Vet Res; 2020 Feb; 81(2):159-171. PubMed ID: 31985287
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of platelet α2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses.
Hikasa Y; Masuda K; Asakura Y; Yamashita Y; Sato C; Kamio M; Miura A; Taniguchi T; Minamizuru N
Eur J Pharmacol; 2013 Nov; 720(1-3):363-75. PubMed ID: 24120658
[TBL] [Abstract][Full Text] [Related]
7. Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.
Grant JA; Scrutton MC
Br J Pharmacol; 1980; 71(1):121-34. PubMed ID: 6110451
[TBL] [Abstract][Full Text] [Related]
8. Effect of imidazoline drugs on human blood platelet aggregation.
Petrusewicz J; Kaliszan R
Thromb Haemost; 1985 Dec; 54(4):784-7. PubMed ID: 2868542
[TBL] [Abstract][Full Text] [Related]
9. The effects of alpha adrenergic agents on human platelet aggregation.
Hsu CY; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1979 Mar; 208(3):366-70. PubMed ID: 34707
[TBL] [Abstract][Full Text] [Related]
10. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Olmos G; Kulkarni RN; Haque M; MacDermot J
Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
[TBL] [Abstract][Full Text] [Related]
11. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
12. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
Andurkar SV; Gendler L; Gulati A
Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameter.
Spada CS; Nieves AL; Burke JA; Wheeler LA; Woodward DF
J Ocul Pharmacol Ther; 2001 Jun; 17(3):255-77. PubMed ID: 11436946
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
[TBL] [Abstract][Full Text] [Related]
16. Adrenaline inhibits adenosine diphosphate induced intravascular aggregation of rat platelets through stimulation of alpha 2 adrenoceptors.
Oyekan AO; Botting JH
Cardiovasc Res; 1991 May; 25(5):431-7. PubMed ID: 1677313
[TBL] [Abstract][Full Text] [Related]
17. Potentiating effect of adrenaline on adenosine diphosphate-induced reduction in rabbit circulating platelet count: inhibition by dihydroergotoxine.
Holmes IB
Thromb Haemost; 1979 Aug; 42(2):641-8. PubMed ID: 41335
[TBL] [Abstract][Full Text] [Related]
18. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
[TBL] [Abstract][Full Text] [Related]
19. Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells.
Kerry R; Scrutton MC
Br J Pharmacol; 1983 Jun; 79(2):401-7. PubMed ID: 6140040
[TBL] [Abstract][Full Text] [Related]
20. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine.
Mustonen P; Savola J; Lassila R
Thromb Res; 2000 Aug; 99(3):231-7. PubMed ID: 10942789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
